Home › Metabolic Disorders › Alabama
Metabolic Disorders clinical trials in Alabama
3 studies for Metabolic Disorders are looking for participants at sites in Alabama.
Cities in Alabama
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Birmingham
- 89bio Clinical Study Site, Homewood
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Birmingham
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT04055428From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.